No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SILK240719P25000
- 0.03
- +0.02+200.00%
15min DelayClose Jul 19 15:44 ET
0.04High0.02Low
0.02Open0.01Pre Close5 Volume610 Open Interest25.00Strike Price15.00Turnover485.14%IV7.76%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0520Delta0.0791Gamma902.33Leverage Ratio-1.7915Theta0.0000Rho-46.95Eff Leverage0.0003Vega
Intraday
- 5D
- Daily
News
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Express News | Silk Road Medical Inc : Stifel Raises Target Price to $27.5 From $23
Express News | Silk Road Medical Inc : Stifel Cuts to Hold From Buy
Express News | Stifel Downgrades Silk Road Medical to Hold, Raises Price Target to $27.5
Stifel Downgrades Silk Road Medical(SILK.US) to Hold Rating, Raises Target Price to $27.5
Stifel analyst Rick Wise downgrades $Silk Road Medical(SILK.US)$ to a hold rating, and adjusts the target price from $23 to $27.5.According to TipRanks data, the analyst has a success rate of 57.9%
Argus Research Downgrades Silk Road Medical(SILK.US) to Sell Rating
Argus Research analyst David Toung downgrades $Silk Road Medical(SILK.US)$ to a sell rating.According to TipRanks data, the analyst has a success rate of 62.0% and a total average return of 9.3%
Comments
$Silk Road Medical(SILK.US$ 1.16 Billion deal 👀
Insider's recent share sale at current price is viewed negatively. Absence of insider purchases and history of sales over the past year raises caution for potential investors. Despite insider ownership, alignment with other shareholders is weak.
Rising insider sales at Silk Road Medical and no insider purchases in past year suggest potential dip in stock performance. Also, low insider ownership suggests less motivation for long-term company growth.
Read more
ElusiveTrader : BOE president election. they cut rates for the people
. too much "economic restraint"